151 related articles for article (PubMed ID: 20633549)
1. 8-Prenylnaringenin is an inhibitor of multidrug resistance-associated transporters, P-glycoprotein and MRP1.
Wesołowska O; Wiśniewski J; Sroda K; Krawczenko A; Bielawska-Pohl A; Paprocka M; Duś D; Michalak K
Eur J Pharmacol; 2010 Oct; 644(1-3):32-40. PubMed ID: 20633549
[TBL] [Abstract][Full Text] [Related]
2. Reversal of doxorubicin resistance by the amiloride analogue EIPA in multidrug resistant human colon carcinoma cells.
Pannocchia A; Revelli S; Tamponi G; Giorgianni A; Todde R; Bosia A; Ghigo D
Cell Biochem Funct; 1996 Mar; 14(1):11-8. PubMed ID: 8907249
[TBL] [Abstract][Full Text] [Related]
3. Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
Wesołowska O; Wiśniewski J; Sroda-Pomianek K; Bielawska-Pohl A; Paprocka M; Duś D; Duarte N; Ferreira MJ; Michalak K
J Nat Prod; 2012 Nov; 75(11):1896-902. PubMed ID: 23137376
[TBL] [Abstract][Full Text] [Related]
4. Intracellular P-glycoprotein expression is associated with the intrinsic multidrug resistance phenotype in human colon adenocarcinoma cells.
Meschini S; Calcabrini A; Monti E; Del Bufalo D; Stringaro A; Dolfini E; Arancia G
Int J Cancer; 2000 Sep; 87(5):615-28. PubMed ID: 10925353
[TBL] [Abstract][Full Text] [Related]
5. Schisandrin B: a dual inhibitor of P-glycoprotein and multidrug resistance-associated protein 1.
Sun M; Xu X; Lu Q; Pan Q; Hu X
Cancer Lett; 2007 Feb; 246(1-2):300-7. PubMed ID: 16621244
[TBL] [Abstract][Full Text] [Related]
6. Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line.
Lelong-Rebel I; Brisson C; Fabre M; Bergerat JP; Rebel G
Anticancer Res; 2008; 28(1A):55-68. PubMed ID: 18383825
[TBL] [Abstract][Full Text] [Related]
7. Euphorbia Species-derived Diterpenes and Coumarins as Multidrug Resistance Modulators in Human Colon Carcinoma Cells.
Wiśniewski J; Wesołowska O; Środa-Pomianek K; Paprocka M; Bielawska-Pohl A; Krawczenko A; Duarte N; Ferreira MJ; Duś D; Michalak K
Anticancer Res; 2016 May; 36(5):2259-64. PubMed ID: 27127131
[TBL] [Abstract][Full Text] [Related]
8. Electroporation adopting trains of biphasic pulses enhances in vitro and in vivo the cytotoxic effect of doxorubicin on multidrug resistant colon adenocarcinoma cells (LoVo).
Meschini S; Condello M; Lista P; Vincenzi B; Baldi A; Citro G; Arancia G; Spugnini EP
Eur J Cancer; 2012 Sep; 48(14):2236-43. PubMed ID: 22240284
[TBL] [Abstract][Full Text] [Related]
9. Development of rational in vitro models for drug resistance in breast cancer and modulation of MDR by selected compounds.
Kars MD; Iseri OD; Gündüz U; Ural AU; Arpaci F; Molnár J
Anticancer Res; 2006; 26(6B):4559-68. PubMed ID: 17201178
[TBL] [Abstract][Full Text] [Related]
10. JNK1, JNK2, and JNK3 are involved in P-glycoprotein-mediated multidrug resistance of hepatocellular carcinoma cells.
Yan F; Wang XM; Liu ZC; Pan C; Yuan SB; Ma QM
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):287-95. PubMed ID: 20525557
[TBL] [Abstract][Full Text] [Related]
11. Differential effect of phenothiazines on MRP1 and P-glycoprotein activity.
Wesołowska O; Molnar J; Ocsovszki I; Michalak K
In Vivo; 2009; 23(6):943-7. PubMed ID: 20023237
[TBL] [Abstract][Full Text] [Related]
12. Indomethacin overcomes doxorubicin resistance with inhibiting multi-drug resistance protein 1 (MRP1).
Matsunaga S; Asano T; Tsutsuda-Asano A; Fukunaga Y
Cancer Chemother Pharmacol; 2006 Sep; 58(3):348-53. PubMed ID: 16331495
[TBL] [Abstract][Full Text] [Related]
13. Organosilicon Compounds, SILA-409 and SILA-421, as Doxorubicin Resistance-Reversing Agents in Human Colon Cancer Cells.
Wesołowska O; Michalak K; Błaszczyk M; Molnár J; Środa-Pomianek K
Molecules; 2020 Apr; 25(7):. PubMed ID: 32260260
[TBL] [Abstract][Full Text] [Related]
14. Effect of MDR modulators verapamil and promethazine on gene expression levels of MDR1 and MRP1 in doxorubicin-resistant MCF-7 cells.
Dönmez Y; Akhmetova L; İşeri ÖD; Kars MD; Gündüz U
Cancer Chemother Pharmacol; 2011 Apr; 67(4):823-8. PubMed ID: 20563580
[TBL] [Abstract][Full Text] [Related]
15. Cediranib (recentin, AZD2171) reverses ABCB1- and ABCC1-mediated multidrug resistance by inhibition of their transport function.
Tao LY; Liang YJ; Wang F; Chen LM; Yan YY; Dai CL; Fu LW
Cancer Chemother Pharmacol; 2009 Oct; 64(5):961-9. PubMed ID: 19255759
[TBL] [Abstract][Full Text] [Related]
16. Reversal of adriamycin resistance by recombinant alpha-interferon in multidrug-resistant human colon carcinoma LoVo-doxorubicin cells.
Scala S; Pacelli R; Iaffaioli RV; Normanno N; Pepe S; Frasci G; Genua G; Tsuruo T; Tagliaferri P; Bianco AR
Cancer Res; 1991 Sep; 51(18):4898-902. PubMed ID: 1893380
[TBL] [Abstract][Full Text] [Related]
17. Effect of new oxicam derivatives on efflux pumps overexpressed in resistant a human colorectal adenocarcinoma cell line.
Środa-Pomianek K; Wesołowska O; Szczęśniak-Sięga B; Puła B; Dzięgiel P; Maniewska J; Malinka W; Palko-Łabuz A; Michalak K
Anticancer Res; 2015 May; 35(5):2835-40. PubMed ID: 25964564
[TBL] [Abstract][Full Text] [Related]
18. Anticancer activity of baicalein and luteolin studied in colorectal adenocarcinoma LoVo cells and in drug-resistant LoVo/Dx cells.
Palko-Labuz A; Sroda-Pomianek K; Uryga A; Kostrzewa-Suslow E; Michalak K
Biomed Pharmacother; 2017 Apr; 88():232-241. PubMed ID: 28110189
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of P-glycoprotein 1 (Pgp1, ABCB1)-mediated doxorubicin-resistant PLHC-1 hepatoma fish cell line.
Zaja R; Caminada D; Loncar J; Fent K; Smital T
Toxicol Appl Pharmacol; 2008 Mar; 227(2):207-18. PubMed ID: 18076962
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin as a fluorescent reporter identifies novel MRP1 (ABCC1) inhibitors missed by calcein-based high content screening of anticancer agents.
Sampson A; Peterson BG; Tan KW; Iram SH
Biomed Pharmacother; 2019 Oct; 118():109289. PubMed ID: 31401398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
